# A Wearable In-phase Chest Wall Vibration Device for Relief of Dyspnoea in COPD: a First-in-human Exploratory Study

> **NCT06432920** · NA · COMPLETED · sponsor: **Elevre Medical Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- Dyspnea

## Interventions

- **DEVICE:** ResWave

## Key facts

- **NCT ID:** NCT06432920
- **Lead sponsor:** Elevre Medical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-06
- **Primary completion:** 2024-01-26
- **Final completion:** 2024-01-26
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06432920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06432920, "A Wearable In-phase Chest Wall Vibration Device for Relief of Dyspnoea in COPD: a First-in-human Exploratory Study". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06432920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*